TGFB1 and neoplasm: Furthermore, Plasmodium immunotherapy inhibits tumor secretion of cytokines and chemokines that could recruit MDSCs, Tregs and other immune suppressor cells into tumor, therefore reduces the numbers of these cells, and decreases the level of their effector molecules (such as IL-10 and TGF-β).